Latham & Watkins and Wilson Sonsini represented Affini-T Therapeutics, Inc. in the transaction.Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic driver…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
